Ophthalmology has evolved from an often overlooked therapeutic area dominated by anti-VEGF injections and surgical treatment to an active pipeline of novel potentially disease-modifying therapies. Current ophthalmological dynamics the REACH team is tracking include:
- The imminent shortage of ophthalmologists to perform intravitreal injections
- Additional approvals of complement targeted therapies for Geographic Atrophy
- Novel approaches across ophthalmology such as stem cell therapy, gene therapy and neuroprotection
Search Ophthalmology diseases we cover